CELAGENEX, LLC, California, USA
Title: Therapeutic Effectiveness of Sulforaphane in a Preclinical Rodent Model of Multiple Sclerosis
Grant: INR 14,45,750
Grant Received On: August 27, 2024
Status: Ongoing
Research Group
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.